Transcriptomic Analysis of the Amygdala in Subjects with Schizophrenia, Bipolar Disorder and Major Depressive Disorder Reveals Differentially Altered Metabolic Pathways

Schizophrenia Bulletin, Journal Year: 2024, Volume and Issue: unknown

Published: Oct. 23, 2024

The amygdala, crucial for mood, anxiety, fear, and reward regulation, shows neuroanatomical molecular divergence in psychiatric disorders like schizophrenia, bipolar disorder major depression. This region is also emerging as an important regulator of metabolic immune pathways. goal this study to address the paucity studies human amygdala. We hypothesize that diagnosis-specific gene expression alterations contribute unique pathophysiological profiles these disorders.

Language: Английский

---

Schizophrenia and Na+/H+ Exchangers

Published: Jan. 1, 2024

---